Issued: 11 December 2025, London UK
Block Listing Application
Application has been made to the Financial Conduct Authority and the London Stock Exchange plc for a total of 250,000 Ordinary Shares of 31¼p each ('Shares') to be admitted to the Official List.
The Shares are being reserved under a block listing and will be issued under the GlaxoSmithKline plc Share Save Plan 2022.
When issued, the Shares will rank pari passu with the existing Ordinary Shares of 31¼p each.
Admission is expected to be effective on 12 December 2025.
V A Whyte
Company Secretary
11 December 2025
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG